U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C20H26N2S.ClH
Molecular Weight 362.96
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ETYMEMAZINE HYDROCHLORIDE

SMILES

Cl.CCC1=CC2=C(SC3=C(C=CC=C3)N2CC(C)CN(C)C)C=C1

InChI

InChIKey=ZVSKDFRXWJPINY-UHFFFAOYSA-N
InChI=1S/C20H26N2S.ClH/c1-5-16-10-11-20-18(12-16)22(14-15(2)13-21(3)4)17-8-6-7-9-19(17)23-20;/h6-12,15H,5,13-14H2,1-4H3;1H

HIDE SMILES / InChI
Molecular Formula C20H26N2S
Molecular Weight 326.499
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Etymemazine (RP-6484), a phenothiazine derivative, is a sedative and neuroleptic agent. It is a histamine H₁-receptor antagonist. It was used to treat dementia. It was also used in veterinary.

Originator

Vaillant-Defresne
2

Approval Year

Unknown
139,594

PubMed

Sample Use Guides

In Vivo Use Guide
Pigs: Ethyl isobutrazine (Etymemazine) and pethidine were each administered at a dose rate of 5 mg/kg
Route of Administration: Intramuscular
Substance Class Chemical
Record UNII
A7002E7T2Z
Record Status Validated (UNII)
Record Version
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966